Translate Bio, Inc. (TBIO) has seen some recent action in the marketplace and its common shares closed at $16.24 yesterday. Investors are starting to take interest of TBIO as the common shares traded as high as $16.33 and as low as $15.09 in the previous market session.

Translate Bio, Inc. (TBIO) average trading volume is 694.85K. However, in the previous market session Translate Bio, Inc. (TBIO) traded 509,737 shares. The First downside support level on TBIO is $16.00 and the First upside resistance level on TBIO is $25.11. TBIO 50-day moving average is $16.54 and TBIO 200-day moving average is $10.83.

Translate Bio, Inc. (TBIO) current performance has been shown by the recent movement in TBIO common shares. TBIO has performed -14.44% over the past month, TBIO has performed 57.82% over the past 3 months and TBIO has shown 29.30% over the past 365 days. Translate Bio, Inc. (TBIO) has a 52 week range of $6.80 to $21.95. Translate Bio, Inc. (TBIO) is trading 138.82% from its 52 week low and -26.01% from its 52 week high. Translate Bio, Inc. (TBIO) is showing a 3.57% short float showing the quantity short in the float.

TBIO has 60.01M shares outstanding and 51.64M shares in the float. Translate Bio, Inc. (TBIO) currently has a market cap of $1.08B and income of -94.40M. The EPS next quarter for TBIO is -0.46 and anticipated EPS next year is -2.70%. The market cap of Translate Bio, Inc. (TBIO) at $1.08B represents how many Investors own shares of TBIO and is based off the last price ($16.24) of TBIO and the quantity of shares outstanding (60.01M) with Translate Bio, Inc. (TBIO).

Translate Bio, Inc. (TBIO) has aggregate cash (mrq) of 155.1M, aggregate cash per share (mrq) of 2.46, aggregate debt of TBIO is at 12.5M and aggregate debt/equity (mrq) is 8.76. . Translate Bio, Inc. (TBIO) operational cash flow (ttm) is -92.08M, TBIO leveraged free cash flow (ttm) is -32.7M.

TBIO is trading -3.63% below (bearish) its SMA20, 8.18% above (bullish) its SMA50 and 55.35% above (bullish) its SMA200.